Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.
about
Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal periodProphylaxis for venous thromboembolic disease in pregnancy and the early postnatal periodVTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesThrombophilia and pregnancyProphylaxis for venous thromboembolic disease in pregnancy and the early postnatal periodPrevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency.Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.The G20210A prothrombin variant and the risk of venous thromboembolism or fetal loss in pregnant women: a family study.Management of venous thromboembolism during pregnancy.Hematologic complications of pregnancy.Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women.Management of inherited thrombophilia: guide for genetics professionals.Evidence-based approach to thrombophilia testing.The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategies.Hypercoagulable state testing and malignancy screening following venous thromboembolic events.Management of thrombophilia.Hormones and pregnancy: thromboembolic risks for women.Lack of Association between Recurrent Pregnancy Loss and Inherited Thrombophilia in a Group of Colombian Patients.Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.Testing for thrombophilia: an evidence-based approach.Postpartum thromboembolism: severe events might be preventable using a new risk score model.Clinical use and the Italian demand for antithrombin.Review of Management and Outcomes in Women with Thrombophilia Risk during Pregnancy at a Single Institution.Recommendations for the prevention of pregnancy-associated venous thromboembolism.Preventing thrombophilia-related complications of pregnancy: an update.Thrombosis in women: what are the knowledge gaps in 2013?Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium.Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysisChanges in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy.High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects.Genetic thrombophilia in patients with VTE in eastern Mediterranean located tertiary care center; is it time to change the algorithm for thrombophilia work up decision making?Left subclavian and right femoral vein thrombosis in a pregnant patient with antithrombin deficiency
P2860
Q24200433-F1B68E0D-7CC3-4C86-B5B3-75F787E54844Q24235476-849F0D86-0D2D-4867-90A4-29887597CC59Q24632982-2289111B-EF35-481D-B091-716ACF35C312Q24801115-7D8B082E-405A-49DE-ADC1-871F8653A769Q28193257-CB374B67-5096-4899-973B-58BA2C41FB62Q30419367-CECD2A9D-32B0-44CA-8E3F-082E51711992Q30587606-5FD0C16A-89C5-42AD-9420-5A0DECC32FD8Q33303765-582C7980-93CE-4433-B77B-5BE5942881C5Q33349065-5BF51D93-59C4-4D46-BFDD-E7C0A49EECAFQ33409852-170D52C0-72A5-43B8-BC58-E21FBB2B0C66Q34127900-CB81B81B-D426-468B-9CC3-3F3DF6E29C44Q34195599-745FA70C-9D75-4A91-AC76-30396EE6346FQ34663749-6FAE1856-BEC4-4770-8A01-D8878D96BF3CQ34824755-DC81C6CB-B1D4-4383-B904-CBC88545CF88Q35179215-31CCD824-C4DF-42E5-BDB1-D75A84069787Q35181607-699361AC-495B-4357-B639-9B6DF472003FQ35852845-BAB9D31B-032D-4044-8D44-5B41CF814C7AQ35936785-B5537529-AA92-4131-AC6B-A7951E84A74BQ36471056-75A793EF-5777-4628-B872-6784935338BFQ36651065-64152328-ACBD-4DAA-9EB9-7FB8B6736C8FQ37019929-37EFE2E5-73F0-4D1D-8C56-74DC1006AFB6Q37370321-AA702CBD-29AE-429A-B2DA-18E248DDAADFQ37622772-F2DFE5A3-386C-4FB6-9C79-738DB66488BCQ37939191-57580601-328E-4E8C-B68A-F9C7AD9A972FQ38115587-D7D7787D-3EDA-4EB5-9FA1-A683DD3CFD95Q38117735-73668677-095B-44FF-A966-870745483D18Q39405390-698455A1-59E2-487D-AA68-D476507A453AQ42626063-FA858B63-CF7B-46B9-920E-1384799E3169Q46630894-30997775-7D1C-4EDA-A496-1B2548CA4BA7Q51102446-C23FEA31-7BEE-4738-86B7-CC20BD4065AEQ51942184-2C063CC8-6ACF-46F8-B12F-FFBD873BEF4FQ57138825-EE4DC23D-7B88-421F-94AB-27090E857A1C
P2860
Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Frequency of pregnancy-related ...... implications for prophylaxis.
@en
Frequency of pregnancy-related ...... implications for prophylaxis.
@nl
type
label
Frequency of pregnancy-related ...... implications for prophylaxis.
@en
Frequency of pregnancy-related ...... implications for prophylaxis.
@nl
prefLabel
Frequency of pregnancy-related ...... implications for prophylaxis.
@en
Frequency of pregnancy-related ...... implications for prophylaxis.
@nl
P2093
P1476
Frequency of pregnancy-related ...... implications for prophylaxis.
@en
P2093
Friederich PW
Girolami A
Huisman MV
Prandoni P
P304
P356
10.7326/0003-4819-125-12-199612150-00003
P407
P577
1996-12-01T00:00:00Z